Weitere Kapitel dieses Buchs durch Wischen aufrufen
Epidemiological studies may investigate the intrinsic toxicity and carcinogenicity together with smokers’ behavioural responses to addiction to assess the full consequences of smoking. Hence, the chemical processes in the development of diseases caused by smoking will be addressed before discussing the consequences of smoking to health. The intrinsic toxicity will be discussed as well as the behavioural and carcinogenicity responses of the smokers, and the social and private costs of smoking. Nicotine is only one of the more than 4000 chemicals in cigarettes which severely affect the health of smokers and non-smokers. Over 40 diseases have been identified as being caused by smoking, so that there are considerable detrimental social and private costs involved as a consequence of smoking.
Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten
Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:
Aizen, E., & Gilhar, A. (2001). Smoking effect on skin wrinkling in the aged population. International Journal of Dermatology, 40(7), 431–433. CrossRef
Almond, D., Chay, K. Y. et al. (2005, August). The costs of low birth weight. Quarterly Journal of Economics, 120(3), 1031–1083.
Barnum, H. (1994). The economic burden of the global trade in tobacco. Tobacco Control, 3(4), 358–361. CrossRef
Bartley, M., Blane, D. et al. (1997). Socio-economic determinants of health: health and life course: why safety nets matter. British Medical Journal, 314(7088), 1194–1196. CrossRef
Blakely, T., & Wilson, N. (2005). The contribution of smoking to inequalities in mortality by education varies over time and by sex: Two national cohort studies, 1981-84 and 1996-99. International Journal of Epidemiology, 34(5), 1054–1062. CrossRef
Cena, H., Fonte, M. L. et al. (2011). Relationship between smoking and metabolic syndrome. Nutrition Reviews, 69(12), 745–753. CrossRef
Chang, C. M., Corey, C. G. et al. (2015). Systematic review of cigar smoking and all cause and smoking related mortality. Bio Med. Central Public Health, 15(1), 1–20. CrossRef
Corrêa, P., Barreto, S. M. et al. (2009). Smoking attributable mortality and years of potential life lost in 16 Brazilian capitals, 2003: A prevalence- based study. BioMed Central, http://www.biomedcentral.com/471-2458/9/206.
Doll, R. (1983). Prospects for prevention. British Medical Journal, 286(6363), 445–453. CrossRef
Doll, R. (1998). Uncovering the effects of smoking: Historical perspective. Statistical Methods in Medical Research, 7(2), 87–117. CrossRef
Doll, R., & Peto, R. (1976). Mortality in relation to smoking: 20 years’ observations on male British doctors. British Medical Journal, 4, 1525–1536. CrossRef
El-Zayadi, A. R. (2006). Heavy Smoking and Liver. World Journal of Gastroenterology, 12(38), 6098–6101. CrossRef
Ezzati, M., & Lopez, A. D. (2003a). Estimates of global mortality attributable to smoking in 2000. Lancet, 362(9387), 847–852. CrossRef
Ezzati, M., & Lopez, A. D. (2003b). Measuring the accumulated hazards of smoking: Global and regional estimates for 2000. Tobacco Control, 12(1), 79–85. CrossRef
Fan, G.-B., Wu, P.-L. et al. (2012). Changes of oxygen content in facial skin before and after cigarette smoking. Skin Research and Technology, 18(4), 511–515. CrossRef
Flegal, K. M. (2007). The effects of changes in smoking prevalence on obesity prevalence in the United States. American Journal of Public Health, 97, 1510–1514. CrossRef
Giles, G., Hill, G. et al. (1991). The lung cancer epidemic in Australia. 1919-1989. Australian Journal of Public Health, 15(3), 245–247. CrossRef
Giovino, Mirza, Samet, et al. (2012). Tobacco use in 3 billion individuals from 16 countries: An analysis of nationally representative cross-sectional household surveys. Lancet, 380, 668–679. CrossRef
Glantz, S. A., & Parmley, W. W. (1995). Passive smoking and heart disease. Mechanisms and risk”. Journal of the American Medical Association, 273(13), 1047–1053. CrossRef
Goldenberg, M., Danovitch, I. et al. (2014). Quality of life and smoking. The American Journal on Addictions, 23(6), 540–562. CrossRef
Haslam, D. W., & James, W. P. (2005). Obesity. Lancet, 366, 1197–1209. CrossRef
Health Canada (2000). Straight Facts About Drugs & Drug Abuse. Ottawa, ON: Government of Canada.
Himbury, S., & West, R. (1984). Smoking habits after laryngectomy. British Medical Journal, 291, 514–515. CrossRef
Jacobs, M. (1995). From the first to the last ash: The history, economics & hazards of tobacco. A comprehensive adult basic education curriculum. The Cambridge Tobacco Education Program, Cambridge Department of Human Service Programs. Revised 1997. Cambridge, MA: Marjorie Jacobs Community Learning Center.
Jiu, S., Lu, B. et al. (1995). An evaluation of smoking-induced health costs in China (1988–1998). Biomedical and Environmental Sciences, 8, 342–349.
Kadunce, D. F., Burr, R. et al. (1991). Cigarette smoking: Risk factor for premature facial wrinkling. Annals of Internal Medicine, 114(10), 840–844. CrossRef
Kahn, R. S., Certai, L. et al. (2002). A re-examination of smoking before, during and after pregnancy. American Journal of Public Health, XCII, 1801–1808. CrossRef
Kendirci, M., Nowfar, S. et al. (2005). The impact of vascular risk factors on erectile function. Drugs of Today, 41(1), 65–74. CrossRef
Klesges, R. C., & Shumaker, S. A. (1992). Understanding the relationship between smoking and body weight and their importance to smoking cessation and relapse. Health Psychology, 11(Suppl.), 1–3. CrossRef
Kramer, M. S. (1987). Intrauterine growth and gestational duration determinants. Paediatrics, 80(4) LXXX, 502–511.
Lewit, E. M. (1989). U.S. tobacco taxes: Behavioural effects and policy implications. British Journal of Addiction, 84, 1217–1235. CrossRef
Lewit, E. M., Hyland, A. et al. (1997). Price, public policy, and smoking in young people. Tobacco Control, 6(Suppl. 2), S17–S24. CrossRef
Liu, Y., Rao, K. et al. (2006). Cigarette smoking and poverty in China. Social Science & Medicine, 63, 2784–2790. CrossRef
Mackay, J. (1997). Beyond the clouds – tobacco smoking in China. Journal of the American Medical Association, 278(18), 1531–1532. CrossRef
Mackenbach, J. P., Bos, V. et al. (2003). Widening socio-economic inequalities in mortality in six Western European countries. International Journal of Epidemiology, 32(5), 830–837. CrossRef
Malone, R. E., McDaniel, P. A. et al. (2014). Report commissioned by cancer research UK. London: Cancer Research UK.
Marmot, M. G., & McDowall, M. E. (1986). Mortality decline and widening social inequalities. Lancet, 328, 274–276. CrossRef
Mathers, C. D., & Loncar, D. V. (2006). Projections of global mortality and burden of disease from 2002 to 2030. Public Library of Science. PLoS Med, 3(11), e442: 2011–2030.
Mizoue, T., Ueda, R., et al. (1998). Body mass decrease after initial gain following smoking cessation. International Journal of Epidemiology, 27, 984–989. CrossRef
Mokdad, A. H., Marks, J. S. et al. (2004). Actual causes of death in the United States, 2000. JAMA, 291, 1238–1245. CrossRef
Nonnemaker, J., Finkelstein, E. et al. (2009). Have efforts to reduce smoking really contributed to the obesity epidemic? Economic Inquiry, 47(2), 366–376. CrossRef
Pauly, J. R., & Slotkin, T. A. (2008). Maternal tobacco smoking, nicotine replacement and neurobehavioural development. Acta Pædiatrica, 97, 1331–1337. CrossRef
Pittilo, R. M. (2000). Cigarette smoking, endothelial injury and cardiovascular disease. International Journal of Experimental Pathology, 81, 219–230. CrossRef
Prabhat, J., Richard, P. et al. (2006). Social inequalities in male mortality, and in male mortality from smoking: indirect estimation from national death rates in England and Wales, Poland and North America. Lancet, 368(9533), 367–370. CrossRef
Proctor, R. N. (2001). Tobacco and the global lung cancer epidemic. Nature Reviews Cancer, 1, 82–86. CrossRef
Raalte, V. A., Kunst, A. E. et al. (2011). More variation in lifespan in lower educated groups: Evidence from 10 European countries. International Journal of Epidemiology, 40, 1703–1714. CrossRef
Shaw, C., Blakely, T. et al. (2005). Varying evolution of the New Zealand lung cancer epidemic by ethnicity and socioeconomic position (1981–1999). The New Zealand Medical Journal, 118(1213), 1411.
Shaw, M., Mitchell, R. et al. (2000). Time for a smoke? One cigarette reduces your life by 11 minutes. British Medical Journal, 3220, 53. CrossRef
Sloan, F. A., Ostermann, J. et al. (2004). The price of smoking. Cambridge, MA: MIT Press.
Tang, L., Lim, W.-Y. et al. (2010). Lung cancer in Chinese women: Evidence for an interaction between tobacco smoking and exposure to inhalants in the indoor environment. Environmental Health Perspectives, 118(9), 1257–1260. CrossRef
Thapar, A., Fowler, T. et al. (2003). Maternal smoking during pregnancy and attention deficit hyperactivity disorder symptoms in offspring. American Journal of Psychiatry, 160, 1985–1989. CrossRef
The United States Department of Health & Human Services. (1989). Smoking tobacco & health. Centers for Disease Control. Washington, DC: National Center for Chronic Disease Prevention and Health Promotion.
Wagstaff, A. (1987). Government prevention policy and the relevance of social cost estimates. British Journal of Addiction, 82, 461–467. CrossRef
World Health Organization (WHO). (2011). Tobacco free initiative: Why is tobacco a public health priority? Geneva: WHO. http://www.who.int/tobacco/health.priority/en.
World Health Organization (WHO). (2012a). Global progress report on the implementation of the WHO framework of the WHO framework convention on tobacco control. Geneva: WHO.
- The Consequences of Smoking
Neuer Inhalt/© Stellmach, Neuer Inhalt/© Maturus, Pluta Logo/© Pluta